Thursday, October 29, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Eli Lilly lifts revenue outlook as weight-loss shots offset Foundayo sales miss, shares jump

TR

By Tom Reyes · Markets Editor

Oct 29 12:29 ETSource: Reuters

From the source

Eli Lilly lifts revenue outlook as weight-loss shots offset Foundayo sales miss, shares jump

Read at reuters.com

Source URL https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-lifts-revenue-outlook-weight-loss-drug-sales-trims-profit-view-deal-2026-10-29/

Prescribed peptides from $99/moSee all →